The purpose of this study is to compare the tolerability of the application of a combination of a serum containing human bone marrow stem cell derived growth factor (SCR Complex) and cytokines and a botanical lipid-based occlusive (Bio Cel) immediately following fractional radiofrequency treatment using the Venus Viva versus standard of care.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Subject Treatment Tolerability Score Post Treatment 1 at 24hrs Post Treatment
Timeframe: 24hr post treatment one
Subject Treatment Tolerability Score Post Treatment 1 at 72hrs Post Treatment
Timeframe: 72 hrs post treatment one
Subject Treatment Tolerability Score Post Treatment 2 at 24hrs Post Treatment
Timeframe: 24hr post treatment two
Subject Treatment Tolerability Score Post Treatment 2 at 72 Hrs Post Treatment
Timeframe: 72hr post treatment two